Supreme Court bars stem cell therapy for autism

Any stem cell intervention for autism given outside an approved, monitored clinical trial is unethical and will be treated as medical malpractice, the Supreme Court has ruled. Patients already receiving such therapy must be re-routed into properly approved trials under the National Medical Commission, AIIMS and the health ministry rather than continuing it as routine care. (NDTV)

• Any stem cell intervention for autism given outside an approved, monitored clinical trial is unethical and will be treated as medical malpractice, the Supreme Court has ruled.
• Patients already receiving such therapy must be re-routed into properly approved trials under the National Medical Commission, AIIMS and the health ministry rather than continuing it as routine care.